Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
about
Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapyCXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasisAntibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerCXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activationPI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cellsDedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development.The role of chemoattractant receptors in shaping the tumor microenvironment.The emerging role of CXC chemokines and their receptors in cancer.Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.Roles of tumor suppressors in regulating tumor-associated inflammation.Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma.A high-fat diet containing lard accelerates prostate cancer progression and reduces survival rate in mice: possible contribution of adipose tissue-derived cytokinesCXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis.Understanding and targeting osteoclastic activity in prostate cancer bone metastases.Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition.Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain.Chemokines: key players in cancer progression and metastasis.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasionCastration-induced changes in mouse epididymal white adipose tissue.CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.
P2860
Q24295209-504032E6-5295-4C90-863A-D4D6D4DCD2C8Q24631961-A40DF51E-9D76-4EF1-BFB2-4FB807DC8FB3Q28304012-B35BD5A7-B6F2-468D-B12F-406516A2AEEBQ28388072-8A3F1423-EEA1-44EE-B4F4-23F504668170Q28391721-77858179-E004-40E3-BA63-FEED34E3A537Q28395725-80F95A0F-580F-44DA-AA5C-7F748023CF55Q30008878-CA32594F-D3B6-409D-8ED6-148EB7F1D22BQ33993124-02F3D2B9-3D3A-46B4-B19B-CB04FEA4DB12Q34263645-D4CDA5C4-5598-46CF-B948-0F19EC5566DDQ34383988-3A838B1C-7034-4E26-8543-059F68F2F6AEQ34413441-0034934D-8BD0-4DC6-9707-34D617B1E754Q34432823-55CD4FFD-1FD9-421A-98B3-9DAB41339B37Q35585932-034337C2-4F9D-42A7-A19A-D4C0E2457974Q35968894-EE4D1DD6-FC1C-4779-8F0F-FF87AEC2FF05Q36693094-59B4ACBD-A683-435B-902E-6630751CBE8EQ36742625-CB53149A-5705-4EC7-8942-690EF13581FEQ36759374-E25A4093-11E6-4EE6-A35B-3808EC78A376Q37078475-75BA8C30-473F-498C-999A-73D082774BFFQ37174010-2667DBB3-663D-4674-B8E0-02F214571377Q37481670-7971DEB9-B383-447C-96A8-DEB0C61E5270Q37881763-C791E282-3E4C-4741-9F46-39DDFA0D652CQ38161395-A63ADB11-49C1-4C37-B82B-4A0EA9B2CAB0Q38707987-281C71D6-AAF6-484F-A55C-3ABC556C5647Q38753469-5861F4F6-C664-45CE-8D79-E0C3662B3AE2Q38913449-8A3F86E3-08DE-4BBA-8327-E1A93A808902Q38932126-339136B4-0E8C-4BAD-8FD6-9AA71CE45175Q41593121-E9EBEB70-2162-4CC2-96AC-EAE26ED21AC0Q41836211-5FB38A64-19A6-4DC1-A61B-C2ABF9424AACQ48099359-3C092FEC-6166-4C58-97CA-F236F2055348
P2860
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@ast
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@en
type
label
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@ast
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@en
prefLabel
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@ast
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@en
P2093
P2860
P1433
P1476
Serum CXCL13 positively correl ...... clustering and cell adhesion.
@en
P2093
Carlton R Cooper
James W Lillard
Kristian R Novakovic
Leland W K Chung
Rajesh Singh
Shailesh Singh
Shesh N Rai
Udai P Singh
William E Grizzle
P2860
P356
10.1016/J.CANLET.2009.03.022
P407
P577
2009-04-17T00:00:00Z